The officials of Pharmacopoeia of Mexico and the US met in Mexico under the FEUM-USP Scientific Meeting 2015 to analyze and update the tests to be applied to medical devices to confirm the standardization of quality, safety and therapeutic efficacy for patients. The official from COFEPRIS, the healthcare regulatory body of Mexico, has emphasized on the significance of sharing of information and review of analytical models between the two pharmacopoeias to ensure the quality and safety of medical equipment being supplied to patients. He also mentioned that the government of Mexico is committed to update and renew the regulatory skeleton for medical devices as per the best global practices. The USP official stated that such bilateral scientific conferences are important to ensure the quality and safety of medical equipments being delivered. The Pharmacopoeial commissions of both the countries play an important role for the well-organized regulation of medical equipment to ensure the quality and safety of products. It was the fifth meeting between both the pharmacopoeias.
Pharmacopoeia professionals of Mexico & US coordinate to review and update tests for quality & safety of medical devices
GHI Analysis1 min read
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
Análisis GHI
Latin America Outlook
Latin America Outlook
Latin America’s political leaders have faced the rigorous challenge of governing a growing and increasingly…
GHI Analysisfebrero 24, 2017
News
Philips, Janssen Pharmaceutical enter into multi-year collaboration to develop blood-based diagnostic for brain disorders
Philips, Janssen Pharmaceutical enter into multi-year collaboration to develop blood-based diagnostic for brain disorders
Philips has signed a multi-year partnership deal with Janssen Pharmaceutical, a Johnson & Johnson company,…
GHI Analysisabril 7, 2015
News
Boston Scientific stands strong in BRIC zone despite tough economic conditions
Boston Scientific stands strong in BRIC zone despite tough economic conditions
According to a report published by Zacks, Boston Scientific is holding its position in the…
GHI Analysisoctubre 5, 2015